JP2013505287A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013505287A5 JP2013505287A5 JP2012530331A JP2012530331A JP2013505287A5 JP 2013505287 A5 JP2013505287 A5 JP 2013505287A5 JP 2012530331 A JP2012530331 A JP 2012530331A JP 2012530331 A JP2012530331 A JP 2012530331A JP 2013505287 A5 JP2013505287 A5 JP 2013505287A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- clearing agent
- enzyme
- agent according
- peptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 50
- 239000003795 chemical substances by application Substances 0.000 claims 27
- 102000004190 Enzymes Human genes 0.000 claims 21
- 108090000790 Enzymes Proteins 0.000 claims 21
- 230000027455 binding Effects 0.000 claims 15
- 102000004196 processed proteins & peptides Human genes 0.000 claims 9
- 238000000034 method Methods 0.000 claims 8
- 150000001413 amino acids Chemical class 0.000 claims 6
- 102000005427 Asialoglycoprotein Receptor Human genes 0.000 claims 4
- 108010006523 asialoglycoprotein receptor Proteins 0.000 claims 4
- 230000000694 effects Effects 0.000 claims 4
- 108010062699 gamma-Glutamyl Hydrolase Proteins 0.000 claims 4
- 210000003494 hepatocyte Anatomy 0.000 claims 4
- 210000004185 liver Anatomy 0.000 claims 4
- 239000004220 glutamic acid Substances 0.000 claims 3
- 229940002612 prodrug Drugs 0.000 claims 3
- 239000000651 prodrug Substances 0.000 claims 3
- 238000012360 testing method Methods 0.000 claims 3
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 238000010494 dissociation reaction Methods 0.000 claims 2
- 230000005593 dissociations Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 108091005601 modified peptides Proteins 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- CXOWHCCVISNMIX-UHFFFAOYSA-N 2-aminonaphthalene-1-carboxylic acid Chemical compound C1=CC=CC2=C(C(O)=O)C(N)=CC=C21 CXOWHCCVISNMIX-UHFFFAOYSA-N 0.000 claims 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims 1
- 108090000204 Dipeptidase 1 Proteins 0.000 claims 1
- 108010016626 Dipeptides Proteins 0.000 claims 1
- 101001133631 Lysinibacillus sphaericus Penicillin acylase Proteins 0.000 claims 1
- 102000004459 Nitroreductase Human genes 0.000 claims 1
- 108010067902 Peptide Library Proteins 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- 102000006995 beta-Glucosidase Human genes 0.000 claims 1
- 108010047754 beta-Glucosidase Proteins 0.000 claims 1
- -1 beta-glucoronidase Proteins 0.000 claims 1
- 102000006635 beta-lactamase Human genes 0.000 claims 1
- 230000004071 biological effect Effects 0.000 claims 1
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000001279 glycosylating effect Effects 0.000 claims 1
- 230000013595 glycosylation Effects 0.000 claims 1
- 238000006206 glycosylation reaction Methods 0.000 claims 1
- 230000005847 immunogenicity Effects 0.000 claims 1
- 108020001162 nitroreductase Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims 1
- 230000009870 specific binding Effects 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
- 210000004881 tumor cell Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0916749.5A GB0916749D0 (en) | 2009-09-23 | 2009-09-23 | Peptide cleaning agents |
| GB0916749.5 | 2009-09-23 | ||
| PCT/GB2010/001796 WO2011036457A1 (en) | 2009-09-23 | 2010-09-23 | Peptide clearing agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013505287A JP2013505287A (ja) | 2013-02-14 |
| JP2013505287A5 true JP2013505287A5 (https=) | 2013-11-14 |
Family
ID=41327500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012530331A Pending JP2013505287A (ja) | 2009-09-23 | 2010-09-23 | ペプチドクリアリング剤 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8846861B2 (https=) |
| EP (1) | EP2470216A1 (https=) |
| JP (1) | JP2013505287A (https=) |
| KR (1) | KR20120084298A (https=) |
| CN (1) | CN102665768B (https=) |
| AU (1) | AU2010299643B2 (https=) |
| BR (1) | BR112012006389A2 (https=) |
| CA (1) | CA2774081A1 (https=) |
| GB (1) | GB0916749D0 (https=) |
| IL (1) | IL218713A0 (https=) |
| IN (1) | IN2012DN02241A (https=) |
| MX (1) | MX2012003565A (https=) |
| NZ (1) | NZ598802A (https=) |
| SG (1) | SG179015A1 (https=) |
| WO (1) | WO2011036457A1 (https=) |
| ZA (1) | ZA201201527B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2435510A (en) | 2006-02-23 | 2007-08-29 | Mologic Ltd | Enzyme detection product and methods |
| US9850296B2 (en) | 2010-08-10 | 2017-12-26 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| EP2603520A4 (en) | 2010-08-10 | 2014-02-19 | Ecole Polytech | ERYTHROCYTE BINDING THERAPEUTICS |
| US9517257B2 (en) | 2010-08-10 | 2016-12-13 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| US10953101B2 (en) | 2014-02-21 | 2021-03-23 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| SG11201606761RA (en) | 2014-02-21 | 2016-09-29 | Ecole Polytecnique Federale De Lausanne Epfl Epfl Tto | Glycotargeting therapeutics |
| US10046056B2 (en) | 2014-02-21 | 2018-08-14 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| US10946079B2 (en) | 2014-02-21 | 2021-03-16 | Ecole Polytechnique Federale De Lausanne | Glycotargeting therapeutics |
| WO2018232176A1 (en) | 2017-06-16 | 2018-12-20 | The University Of Chicago | Compositions and methods for inducing immune tolerance |
| EP3790577A4 (en) | 2018-05-09 | 2022-04-27 | The University of Chicago | COMPOSITIONS AND METHODS RELATED TO IMMUNTOLERANCE |
| WO2021155317A1 (en) | 2020-01-31 | 2021-08-05 | Avilar Therapeutics, Inc. | Asgpr-binding compounds for the degradation of extracellular proteins |
| KR20240017423A (ko) | 2021-05-03 | 2024-02-07 | 아빌라 테라퓨틱스, 인크. | 이뮤노글로불린 및 다른 단백질의 분해를 위한 강력한 asgpr-결합 화합물 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6075010A (en) | 1992-06-09 | 2000-06-13 | Neorx Corporation | Small molecular weight ligand-hexose containing clearing agents |
| US4859449A (en) | 1987-09-14 | 1989-08-22 | Center For Molecular Medicine And Immunology | Modified antibodies for enhanced hepatocyte clearance |
| US20030068322A1 (en) | 1988-04-18 | 2003-04-10 | Immunomedics, Inc. | Methods of antibody-directed enzyme-prodrug therapy |
| EP0538268A4 (en) | 1990-05-11 | 1993-05-12 | The University Of Connecticut | Targeted protection from cytotoxins |
| GB9324807D0 (en) | 1993-12-03 | 1994-01-19 | Cancer Res Campaign Tech | Tumour antibody |
| US6172045B1 (en) * | 1994-12-07 | 2001-01-09 | Neorx Corporation | Cluster clearing agents |
| ATE458499T1 (de) | 1995-06-07 | 2010-03-15 | Immunomedics Inc | Verbesserte abgabe von diagnostischen und therapeutischen stoffen an einem zielort |
| GB9524942D0 (en) * | 1995-12-06 | 1996-02-07 | Aepact Ltd | Drug therapy |
| CA2270394A1 (en) * | 1996-10-31 | 1998-05-07 | Novalon Pharmaceutical Corporation | Identification of drugs using complementary combinatorial libraries |
| GB9624993D0 (en) * | 1996-11-30 | 1997-01-15 | Aepact Ltd | Tumour therapy |
| US7138103B2 (en) | 1998-06-22 | 2006-11-21 | Immunomedics, Inc. | Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| US6962702B2 (en) * | 1998-06-22 | 2005-11-08 | Immunomedics Inc. | Production and use of novel peptide-based agents for use with bi-specific antibodies |
| AU6059699A (en) * | 1998-09-23 | 2000-04-10 | Regents Of The University Of California, The | Synthetic peptides, conjugation reagents and methods |
| DK1379634T3 (en) * | 2001-04-20 | 2018-03-19 | The Univ Of Georgia Research Foundation Inc | ACTIVE LOCATION INACTIVATORS |
| JP2009509535A (ja) * | 2005-09-27 | 2009-03-12 | アムニクス， インコーポレイテッド | タンパク様薬剤およびその使用 |
| EP2050761B1 (en) | 2007-10-16 | 2011-06-29 | Toscana Biomarkers S.r.l. | Galactosylated peptides, their preparation and use in autoimmune diseases diagnosis |
-
2009
- 2009-09-23 GB GBGB0916749.5A patent/GB0916749D0/en not_active Ceased
-
2010
- 2010-09-23 NZ NZ598802A patent/NZ598802A/xx not_active IP Right Cessation
- 2010-09-23 MX MX2012003565A patent/MX2012003565A/es not_active Application Discontinuation
- 2010-09-23 AU AU2010299643A patent/AU2010299643B2/en not_active Ceased
- 2010-09-23 IN IN2241DEN2012 patent/IN2012DN02241A/en unknown
- 2010-09-23 KR KR1020127010173A patent/KR20120084298A/ko not_active Withdrawn
- 2010-09-23 WO PCT/GB2010/001796 patent/WO2011036457A1/en not_active Ceased
- 2010-09-23 SG SG2012015806A patent/SG179015A1/en unknown
- 2010-09-23 EP EP10757623A patent/EP2470216A1/en not_active Withdrawn
- 2010-09-23 JP JP2012530331A patent/JP2013505287A/ja active Pending
- 2010-09-23 US US13/497,967 patent/US8846861B2/en not_active Expired - Fee Related
- 2010-09-23 BR BR112012006389A patent/BR112012006389A2/pt not_active IP Right Cessation
- 2010-09-23 CA CA2774081A patent/CA2774081A1/en not_active Abandoned
- 2010-09-23 CN CN201080042526.6A patent/CN102665768B/zh not_active Expired - Fee Related
-
2012
- 2012-02-29 ZA ZA2012/01527A patent/ZA201201527B/en unknown
- 2012-03-18 IL IL218713A patent/IL218713A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013505287A5 (https=) | ||
| JP7540948B2 (ja) | ペプチド－ｍｈｃ ｃｏｍｐａｃｔ | |
| Müller et al. | Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain | |
| AU2010203353B2 (en) | Modified antibody compositions, methods of making and using thereof | |
| AU784285B2 (en) | Methods and compositions for prolonging elimination half-times of bioactive compounds | |
| CN102665768B (zh) | 肽清除剂 | |
| US20140274759A1 (en) | Modification of polypeptides | |
| RU2010151725A (ru) | Аминокислотные последовательности, направленные против cхcr4 и других gpcr, и соединения, включаюшие их | |
| US20210009660A1 (en) | Recombinant immunoglobulin heavy chains comprising a sortase conjugation loop and conjugates thereof | |
| CA2796181A1 (en) | Heterodimeric antibody fc-containing proteins and methods for production thereof | |
| WO2006036834A3 (en) | MODIFIED Fc MOLECULES | |
| US20190031770A1 (en) | Intercalated single-chain variable fragments | |
| JP2011523550A5 (https=) | ||
| JP2018531235A6 (ja) | ソルターゼ・コンジュゲート化ループを含む組換え免疫グロブリン重鎖およびそのコンジュゲート | |
| JP2017501728A5 (https=) | ||
| EP4251130A1 (en) | Compositions and methods for selective depletion of target molecules | |
| US20210317233A1 (en) | Super Versatile Method for Imparting New Binding Specificity to Antibody | |
| JP2025137512A (ja) | 新規に設計された共局在化依存性タンパク質スイッチを使用する超特異的細胞標的化 | |
| Wang et al. | Folding of flexible protein fragments and design of nanoparticle-based artificial antibody targeting lysozyme | |
| JP2025512798A5 (https=) | ||
| Wang et al. | Chemoenzymatic Site-Specific Lysine Modification of Nanobodies and Subsequent Bioconjugation via Potassium Acyltrifluoroborate (KAT) Ligations | |
| Lee et al. | Use of model peptide reactions for the characterization of kinetically controlled ligation | |
| JP2008506358A5 (https=) | ||
| WO2022087154A1 (en) | Mhc class ii peptide multimers and uses thereof | |
| WO2020198075A2 (en) | Multivalent d-peptidic compounds for target proteins |